成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 16588-24-2 Chemical Structure| 16588-24-2

Structure of 16588-24-2

Chemical Structure| 16588-24-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 16588-24-2

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 16588-24-2 ]

CAS No. :16588-24-2
Formula : C6H3BrClNO2
M.W : 236.45
SMILES Code : BrC1=CC(=C(C=C1)Cl)[N+](=O)[O-]
MDL No. :MFCD05863216
InChI Key :DJRYWPGOQTUJMQ-UHFFFAOYSA-N
Pubchem ID :817974

Safety of [ 16588-24-2 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 16588-24-2 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 47.97
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

45.82 ?2

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.7
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.15
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.01
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.22
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.02
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.22

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.63
Solubility 0.0557 mg/ml ; 0.000235 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.78
Solubility 0.039 mg/ml ; 0.000165 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.25
Solubility 0.132 mg/ml ; 0.000558 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

 High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

 Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

 No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

 Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

 No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

 Yes
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

 No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

 No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.51 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

 0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

 None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

 0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

 0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

 0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

 No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

 2.07

Application In Synthesis of [ 16588-24-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 16588-24-2 ]

[ 16588-24-2 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 16588-24-2 ]
  • [ 1826-67-1 ]
  • [ 126811-30-1 ]
YieldReaction ConditionsOperation in experiment
44%
Stage #1: at -40℃; for 2 h;
Stage #2: With ammonium chloride In tetrahydrofuran; dihydrogen peroxide		 To a solution of 4-bromo-1-chloro-2-nitro-benzene (14 g, 0.059 mol) in 400 mL THF at - 40 °C was added dropwise vinylmagnesium bromide (177 mL of 1.0M solution in THF, 0.177 mol). The reaction mixture was stirred for 2 hrs at -40 °C. Aqueous NH4CI was added and the mixture extracted with ether. The organic phase was dried over Na2S04> concentrated and the residue purified by silica gel column chromatography to give the title compound (6 g, 44 percent). 1H NMR CDCI3400 MHz δ 8.5 (s, 1 H), 7.31-7.29 (m, 1 H), 7.26-7.22 (m, 1 H),7.07-7.05 (m, 1 H), 6.65-6.63 (m,1 H).
44% at -40 - 40℃; for 2 h; To a solution of 4-bromo-1-chloro-2-nitro-benzene (14 g, 0.059 mol) in 400 mL THF at -40° C. was added dropwise vinylmagnesium bromide (177 mL of 1.0M solution in THF, 0.177 mol). The reaction mixture was stirred for 2 hrs at 40° C. Aqueous NH4Cl was added and the mixture extracted with ether. The organic phase was dried over Na2SO4, concentrated and the residue purified by silica gel column chromatography to give the title compound (6 g, 44percent). 1H NMR CDCl3400 MHz δ 8.5 (s, 1H), 7.31-7.29 (m, 1H), 7.26-7.22 (m, 1H), 7.07-7.05 (m, 1H), 6.65-6.63 (m, 1H).
32% at -40℃; for 1 h; Inert atmosphere Under a nitrogen gas, 4-bromo-1-chloro-2-nitrobenzene (25g, 0.107mol) dissolved inTHF (250mL) and then - 40 degree celcius added vinylmagnesium bromide (1M in THF, 321mL, 0.321mol) slowly dropwise, and then stirred at -40 degree celcius for 1 hour. Since, NH4After completion of the reaction with Cl aqueous solution was raised to room temperature.Then, the organic layer was extracted with ethyl acetate, MgSO4to remove moisture in the organic layer, filtered and concentrated and purified by column chromatography to give 4-bromo-7-chloro-1H-indole (7.89g,Yield: 32percent) It was obtained.
References: [1] Patent: WO2013/117522, 2013, A1, . Location in patent: Page/Page column 40.
[2] Patent: US2015/18367, 2015, A1, . Location in patent: Paragraph 0179; 0180.
[3] Patent: KR101601357, 2016, B1, . Location in patent: Paragraph 0392-0394.
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 16588-24-2 ]

Aryls

Chemical Structure| 65001-80-1

A194622 [65001-80-1]

1-Bromo-2,4-dichloro-5-nitrobenzene

Similarity: 0.94

Chemical Structure| 219817-43-3

A367939 [219817-43-3]

1-Bromo-3-chloro-5-nitrobenzene

Similarity: 0.92

Chemical Structure| 59772-48-4

A179376 [59772-48-4]

1-Bromo-3-chloro-2-nitrobenzene

Similarity: 0.91

Chemical Structure| 29682-39-1

A329315 [29682-39-1]

1-Bromo-2-chloro-4-nitrobenzene

Similarity: 0.89

Chemical Structure| 16588-26-4

A107699 [16588-26-4]

3-Bromo-4-chloronitrobenzene

Similarity: 0.89

Bromides

Chemical Structure| 65001-80-1

A194622 [65001-80-1]

1-Bromo-2,4-dichloro-5-nitrobenzene

Similarity: 0.94

Chemical Structure| 219817-43-3

A367939 [219817-43-3]

1-Bromo-3-chloro-5-nitrobenzene

Similarity: 0.92

Chemical Structure| 59772-48-4

A179376 [59772-48-4]

1-Bromo-3-chloro-2-nitrobenzene

Similarity: 0.91

Chemical Structure| 29682-39-1

A329315 [29682-39-1]

1-Bromo-2-chloro-4-nitrobenzene

Similarity: 0.89

Chemical Structure| 16588-26-4

A107699 [16588-26-4]

3-Bromo-4-chloronitrobenzene

Similarity: 0.89

Chlorides

Chemical Structure| 65001-80-1

A194622 [65001-80-1]

1-Bromo-2,4-dichloro-5-nitrobenzene

Similarity: 0.94

Chemical Structure| 219817-43-3

A367939 [219817-43-3]

1-Bromo-3-chloro-5-nitrobenzene

Similarity: 0.92

Chemical Structure| 59772-48-4

A179376 [59772-48-4]

1-Bromo-3-chloro-2-nitrobenzene

Similarity: 0.91

Chemical Structure| 29682-39-1

A329315 [29682-39-1]

1-Bromo-2-chloro-4-nitrobenzene

Similarity: 0.89

Chemical Structure| 16588-26-4

A107699 [16588-26-4]

3-Bromo-4-chloronitrobenzene

Similarity: 0.89

Nitroes

Chemical Structure| 65001-80-1

A194622 [65001-80-1]

1-Bromo-2,4-dichloro-5-nitrobenzene

Similarity: 0.94

Chemical Structure| 219817-43-3

A367939 [219817-43-3]

1-Bromo-3-chloro-5-nitrobenzene

Similarity: 0.92

Chemical Structure| 59772-48-4

A179376 [59772-48-4]

1-Bromo-3-chloro-2-nitrobenzene

Similarity: 0.91

Chemical Structure| 29682-39-1

A329315 [29682-39-1]

1-Bromo-2-chloro-4-nitrobenzene

Similarity: 0.89

Chemical Structure| 16588-26-4

A107699 [16588-26-4]

3-Bromo-4-chloronitrobenzene

Similarity: 0.89